Allianz Lifts Dividend 11% as €2.5bn Buyback and Anthropic Partnership Signal Confidence

Allianz raises 2025 dividend 11% to €17.10 per share, announces €2.5B buyback, and partners with Anthropic for AI. Record net profit of €17.4B supports 4.45% yield.

Allianz is sending a clear message to shareholders: record profits are not just a one-off. The insurer raised its 2025 dividend to €17.10 per share, an 11% jump that extends a decade-long growth streak. Since 2015, the payout has more than doubled, compounding at roughly 6% annually. At the current share price of €383.80, the stock yields 4.45% — well above the average 3% offered by other DAX names.

Behind that increase sits a net profit of €17.4bn for the 2025 fiscal year, a record for the group. But what catches the eye is how aggressively Allianz is deploying its surplus capital. Alongside the dividend, the board authorised a buyback programme of up to €2.5bn that runs through the end of 2026. Since its launch on 13 March, the company has already spent €842.5m to retire 2.27m of its own shares. The pace picked up in late May, with 240,477 shares snapped up over three trading days at an average price of €384.69.

A Bet on Claude

The capital return strategy is not the only move requiring financial muscle. Allianz has struck a global partnership with Anthropic, the US artificial intelligence group behind the Claude family of models. The deal will embed Claude into Allianz’s internal AI platform, giving employees across the group access to tools for research, analysis, and knowledge management. Software engineers will also be able to use “Claude Code” for coding and debugging.

Regulatory compliance is woven into the arrangement from the start. The two companies are jointly developing systems that log every AI decision, including the rationale and the data sources used. A “human-in-the-loop” design ensures that sensitive cases — particularly in underwriting and claims — still pass through a human reviewer. For a regulated insurer that is less a luxury than a necessity.

Analyst Divergence on AI Risk

Not everyone is convinced the AI push is a net positive for the shares. Barclays rates Allianz “underweight” with a price target of €350, citing structural risks that artificial intelligence poses to the insurance business model. The average analyst target, by contrast, sits around €425, implying roughly 11% upside from current levels. The stock trades at a price-to-earnings multiple of 14.1, hardly bargain territory after a strong run.

The earnings engine that funds both the dividend and the buyback remains in fine fettle. In the first quarter of 2026, Allianz posted an operating profit of €4.5bn, up 6.6% year on year. Third-party assets under management hit a record €2.043trn, fuelled by net inflows of €45bn. Management is guiding for full-year profit of €17.4bn — the same as last year’s record — and the solvency II ratio stands at 221%, leaving ample room for further capital returns or investments.

Income Investors Take Note

For those building a dividend-based retirement portfolio, Allianz offers a combination few German stocks can match: a 4.45% yield backed by a payout that has doubled in a decade, plus ongoing share count reduction that lifts per-share metrics. The downside is that the valuation is no longer cheap. Barclays’ warning about AI disruption may prove premature, but it underscores a genuine uncertainty in the insurance sector.

The next milestone is 7 August, when Allianz reports second-quarter results. That dataset will offer the first real clue as to whether the Anthropic partnership is already leaving a footprint on the cost base — and whether a stock that yields 4.45% and buys back at a €384 average price still has room to run.